These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7291145)

  • 21. Juvenile thyrotoxicosis.
    Péter F
    Acta Endocrinol Suppl (Copenh); 1986; 279():361-6. PubMed ID: 3096041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thyroid gland and pregnancy--physiology and pathology].
    Łacka K; Łakoma H
    Wiad Lek; 2002; 55(7-8):450-62. PubMed ID: 12428574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic immunoneutralization of thyrotropin-releasing hormone on the hypothalamic-pituitary-thyroid axis, prolactin, and reproductive function in the ewe.
    Fraser HM; McNeilly AS
    Endocrinology; 1982 Dec; 111(6):1964-73. PubMed ID: 6814896
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperthyroidism and excessive thyrotropin secretion.
    Emerson CH; Utiger RD
    N Engl J Med; 1972 Aug; 287(7):328-33. PubMed ID: 4114408
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
    Rösler A; Litvin Y; Hage C; Gross J; Cerasi E
    J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The hypophyseal-thyroid system in myocardial infarction].
    Pimenov LT
    Sov Med; 1984; (11):7-12. PubMed ID: 6523214
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.
    Snyder PJ; Jacobs LS; Utiger RD; Daughaday WH
    J Clin Invest; 1973 Sep; 52(9):2324-9. PubMed ID: 4199418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypothalamus-pituitary-thyroid axis in patients with hepatic cirrhosis].
    Gong JW; Fu MD; Zhu YF
    Zhonghua Nei Ke Za Zhi; 1987 Mar; 26(3):165-7, 191. PubMed ID: 3113856
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term observation of thyroid function after surgical treatment of thyrotoxicosis.
    Blichert-Toft M; Jorgensen SJ; Hansen JB; Watt-Boolsen S; Christiansen C; Ibsen J
    Acta Chir Scand; 1977; 143(4):221-7. PubMed ID: 906756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reaction of the thyroid gland to a single and prolonged administration of prolactin].
    Pesotskaia PM
    Probl Endokrinol (Mosk); 1985; 31(3):54-6. PubMed ID: 4059197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gestational transient thyrotoxicosis.
    Albaar MT; Adam JM
    Acta Med Indones; 2009 Apr; 41(2):99-104. PubMed ID: 19390130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid function in patients in clinical remission after medical treatment of thyrotoxicosis.
    Hooper MJ; Ratcliffe JG; Ratcliffe WA; Spencer CA; McLarty DG; Alexander WD
    J Clin Endocrinol Metab; 1975 May; 40(5):807-11. PubMed ID: 47864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary and plasma thyrotropin, thyroxine, and triiodothyronine after hyperthyroidism.
    Obregon MJ; Pascual A; de Escobar GM; Escobar del Rey F
    Endocrinology; 1979 May; 104(5):1467-73. PubMed ID: 108095
    [No Abstract]   [Full Text] [Related]  

  • 36. Pernasal versus intravenous administration of TRH: effects on thyrotropin, prolactin, triiodothyronine, thyroxine and thyroglobulin in healthy subjects.
    Schäfgen W; Grebe SF; Schatz H
    Horm Metab Res; 1983 Jan; 15(1):52-3. PubMed ID: 6403447
    [No Abstract]   [Full Text] [Related]  

  • 37. Pituitary-thyroid responses to 4-hour constant infusions of thyrotropin releasing hormone in man.
    Bremner WJ; Abreu R; Stockigt JR; de Kretser DM; Burger HG
    J Clin Endocrinol Metab; 1977 Nov; 45(5):981-7. PubMed ID: 411803
    [No Abstract]   [Full Text] [Related]  

  • 38. [The thyroid gland in patients with sarcoidosis].
    Borisova NK; Ametov AS; Khachatrian EI; Daurov BI; Bondarenko VO
    Probl Tuberk; 1994; (2):35-7. PubMed ID: 8036216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-altitude pituitary-thyroid dysfunction on Mount Everest.
    Mordes JP; Blume FD; Boyer S; Zheng MR; Braverman LE
    N Engl J Med; 1983 May; 308(19):1135-8. PubMed ID: 6835338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.